PADAGIS US Company Profile

✉ Email this page to a colleague

PADAGIS US has eighty-eight approved drugs.

There is one US patent protecting PADAGIS US drugs.

There are twenty-two patent family members on PADAGIS US drugs in fourteen countries and one hundred and twenty-three supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Us	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	CREAM;TOPICAL	086413-003	Approved Prior to Jan 1, 1982	AT	RX	No	No		⤷ Subscribe				⤷ Subscribe
Padagis Us	FLAVOXATE HYDROCHLORIDE	flavoxate hydrochloride	TABLET;ORAL	076831-001	Dec 16, 2004	AB	RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Padagis Us	COMPRO	prochlorperazine	SUPPOSITORY;RECTAL	040246-001	Jun 28, 2000	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Padagis Us	EFINACONAZOLE	efinaconazole	SOLUTION;TOPICAL	211851-001	Dec 16, 2020		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Padagis Us	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	6,013,657	⤷ Subscribe
Padagis Us	EVAMIST	estradiol	SPRAY;TRANSDERMAL	022014-001	Jul 27, 2007	6,978,945	⤷ Subscribe
Padagis Us	BUTOCONAZOLE NITRATE	butoconazole nitrate	CREAM;VAGINAL	019881-001	Feb 7, 1997	5,266,329	⤷ Subscribe
Padagis Us	CLINDESSE	clindamycin phosphate	CREAM;VAGINAL	050793-001	Nov 30, 2004	6,899,890	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Vaginal Cream	2%	➤ Subscribe	2015-02-05
➤ Subscribe	Enteric Coated Capsules	3 mg	➤ Subscribe	2008-02-01

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
European Patent Office	1667619	⤷ Subscribe
Malaysia	144021	⤷ Subscribe
Eurasian Patent Organization	200870154	⤷ Subscribe
Japan	2007505927	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0398460	04C0022	France	⤷ Subscribe	PRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211
2435024	2021C/518	Belgium	⤷ Subscribe	PRODUCT NAME: UNE COMBINAISON DE FORMOTEROL (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), GLYCOPYRROLATE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET BUDESONIDE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1498 20201210
2957286	1990003-4	Sweden	⤷ Subscribe	PRODUCT NAME: PATRIOMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179 20170721
0548114	SPC/GB97/064	United Kingdom	⤷ Subscribe	PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.